JPRN-jRCT2080221311未知3 期
ong-term study of HFT-290 in patients with chronic pain.
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with chronic pain persisting for at least 12 weeks before obtaining informed consent
排除标准
- •- Patients with abnormalities at the site of application
- •- Patients in whom the primary cause of chronic pain (the target of evaluation) is considered to be persistent somatoform pain disorder
- •- Patients who are scheduled to undergo an operation with a potential influence on the evaluation of pain for at least 7 days before starting administration of the investigational drug
研究者
相似试验
未知
3 期
Phase III clinical study in patients with chronic paiChronic painJPRN-jRCT2080221563Hisamitsu Pharmaceutical Co., Inc.
未知
3 期
A phase III clinical study of HFT-290.Cancer painJPRN-jRCT2080223308Hisamitsu Pharmaceutical Co.,Inc.
未知
3 期
ong-term study of HP-3060Perennial allergic rhinitisJPRN-jRCT2080222924Hisamitsu Pharmaceutical Co., Inc.
未知
1 期
Phase I study of ONO-7268MX2Hepatocellular carcinomaJPRN-jRCT2080222427ONO PHARMACEUTICAL CO.,LTD.12
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc